Literature DB >> 16979660

Structural basis of interaction between urokinase-type plasminogen activator and its receptor.

Cyril Barinka1, Graham Parry, Jennifer Callahan, David E Shaw, Alice Kuo, Khalil Bdeir, Douglas B Cines, Andrew Mazar, Jacek Lubkowski.   

Abstract

Recent studies indicate that binding of the urokinase-type plasminogen activator (uPA) to its high-affinity receptor (uPAR) orchestrates uPAR interactions with other cellular components that play a pivotal role in diverse (patho-)physiological processes, including wound healing, angiogenesis, inflammation, and cancer metastasis. However, notwithstanding the wealth of biochemical data available describing the activities of uPAR, little is known about the exact mode of uPAR/uPA interactions or the presumed conformational changes that accompany uPA/uPAR engagement. Here, we report the crystal structure of soluble urokinase plasminogen activator receptor (suPAR), which contains the three domains of the wild-type receptor but lacks the cell-surface anchoring sequence, in complex with the amino-terminal fragment of urokinase-type plasminogen activator (ATF), at the resolution of 2.8 A. We report the 1.9 A crystal structure of free ATF. Our results provide a structural basis, represented by conformational changes induced in uPAR, for several published biochemical observations describing the nature of uPAR/uPA interactions and provide insight into mechanisms that may be responsible for the cellular responses induced by uPA binding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979660      PMCID: PMC3443620          DOI: 10.1016/j.jmb.2006.08.063

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  54 in total

1.  Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.

Authors:  R P Czekay; T A Kuemmel; R A Orlando; M G Farquhar
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  The role of the plasminogen activation system in angiogenesis and metastasis.

Authors:  S A Rabbani; A P Mazar
Journal:  Surg Oncol Clin N Am       Date:  2001-04       Impact factor: 3.495

3.  Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.

Authors:  Nicolai Sidenius; Annapaola Andolfo; Riccardo Fesce; Francesco Blasi
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

4.  Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function.

Authors:  D I Simon; Y Wei; L Zhang; N K Rao; H Xu; Z Chen; Q Liu; S Rosenberg; H A Chapman
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

5.  Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation.

Authors:  A Poliakov; V Tkachuk; T Ovchinnikova; N Potapenko; S Bagryantsev; V Stepanova
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

6.  The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.

Authors:  M Resnati; I Pallavicini; J M Wang; J Oppenheim; C N Serhan; M Romano; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

7.  Peptide-derived antagonists of the urokinase receptor. affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation.

Authors:  M Ploug; S Østergaard; H Gårdsvoll; K Kovalski; C Holst-Hansen; A Holm; L Ossowski; K Danø
Journal:  Biochemistry       Date:  2001-10-09       Impact factor: 3.162

8.  Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis.

Authors:  H Gårdsvoll; K Danø; M Ploug
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

9.  A region in domain II of the urokinase receptor required for urokinase binding.

Authors:  K Bdeir; A Kuo; A Mazar; B S Sachais; W Xiao; S Gawlak; S Harris; A A Higazi; D B Cines
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

10.  Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor.

Authors:  Annapaola Andolfo; William R English; Massimo Resnati; Gillian Murphy; Francesco Blasi; Nicolai Sidenius
Journal:  Thromb Haemost       Date:  2002-08       Impact factor: 5.249

View more
  39 in total

1.  A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.

Authors:  Evelyn C Nieves; Naveen Manchanda
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

2.  Ab initio molecular simulations for proposing novel peptide inhibitors blocking the ligand-binding pocket of urokinase receptor.

Authors:  Tatsuroh Mizushima; Takuya Sugimoto; Tomoyo Kasumi; Kohta Araki; Hiroshi Kobayashi; Noriyuki Kurita
Journal:  J Mol Model       Date:  2014-05-25       Impact factor: 1.810

3.  D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.

Authors:  Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Andrea Motta; Federico Furlan; Valentina Citro; Maria Vittoria Cubellis; Bernard Degryse
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

4.  Number and brightness image analysis reveals ATF-induced dimerization kinetics of uPAR in the cell membrane.

Authors:  Christian Hellriegel; Valeria R Caiolfa; Valeria Corti; Nicolai Sidenius; Moreno Zamai
Journal:  FASEB J       Date:  2011-05-20       Impact factor: 5.191

5.  Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond?

Authors:  Julie M Leth; Haydyn D T Mertens; Katrine Zinck Leth-Espensen; Thomas J D Jørgensen; Michael Ploug
Journal:  J Biol Chem       Date:  2019-03-20       Impact factor: 5.157

6.  Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domains.

Authors:  René Bager; Thomas K Kristensen; Jan K Jensen; Agnieszka Szczur; Anni Christensen; Lisbeth M Andersen; Jesper S Johansen; Niels Larsen; Erik Baatrup; Mingdong Huang; Michael Ploug; Peter A Andreasen
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

Review 7.  Vascular targeting of antithrombotic agents.

Authors:  Ronald Carnemolla; Vladimir R Muzykantov
Journal:  IUBMB Life       Date:  2011-07-15       Impact factor: 3.885

8.  A flexible multidomain structure drives the function of the urokinase-type plasminogen activator receptor (uPAR).

Authors:  Haydyn D T Mertens; Magnus Kjaergaard; Simon Mysling; Henrik Gårdsvoll; Thomas J D Jørgensen; Dmitri I Svergun; Michael Ploug
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

9.  Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.

Authors:  Gretchen A Larusch; Alona Merkulova; Fakhri Mahdi; Zia Shariat-Madar; Robert G Sitrin; Douglas B Cines; Alvin H Schmaier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-24       Impact factor: 4.733

10.  The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization.

Authors:  Yuchuan Liu; Dian J Cao; Irma M Sainz; Yan-Lin Guo; Robert W Colman
Journal:  Am J Physiol Cell Physiol       Date:  2008-05-21       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.